A low interleukin-10 tumor necrosis factor-α ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya

Journal of Infectious Diseases

Volumn 179, Issue 1, 1999, Pages 279-282

  Othoro, Caroline ^a   Lal, Altaf A ^a   Nahlen, Bernard ^a   Koech, Davy ^a   Orago, Alloys S S ^a   Udhayakumar, Venkatachalam ^a  

^a Mai Stop F 12 ^*

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ANEMIA; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDEMIC DISEASE; HUMAN; KENYA; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; PARASITEMIA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

EID: 0013564137     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314548     Document Type: Article

References (15)

1. World Health Organization. World malaria situation in 1993. Wkly Epidemiol Rec 1996;71:17-22.
2. World Health Organization, Division of Control of Tropical Disease. Severe and complicated malaria. Trans R Soc Trop Med Hyg 1990;84(suppl 2): 1-65.
3. Kern P, Henmer CJ, van Damme J, Greiss H, Dietrich M. Elevated TNF-α and IL-6 serum levels as markers for complicated Plasmodium falciparum malaria. Am J Med 1989;87:139-43.
4. Grau G, Taylor T, Molyneux ME et al. Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med 1989;320:1586-91.
5. Kwiatkowski D, Hill AVS, Samban I, et al. TNF concentration in fatal cerebral, non-fatal cerebral and uncomplicated Plasmodium falciparum malaria. Lancet 1990;336:1201-4.
6. Shaffer N, Grau GE, Hedberg K, et al. Tumour necrosis factor and severe malaria. J Infect Dis 1991;163:96-101.
7. Grau GE, Behr C. Cytokines and malaria: for better or worse. In: Aggarwal BB, Puri SK, eds. Human cytokines: their role in disease and therapy. New York: Marcel Dekker, 1995:197-16.
8. Ho M, Sexton MM, Tongtawe P, Looareesuwan S, Suntharasamai P, Webster K. Interleukin-10 inhibits tumor necrosis factor production but not antigen-specific proliferation in acute Plasmodium falciparum malaria. J Infect Dis 1995;172:838-44
9. Wenisch C, Parschalk B, Narzt E, Looareesuwan S, Graninger W. Elevated serum levels of IL-10 and IFN-γ in patients with acute Plasmodium malaria. Clin Immunol Immunopathol 1995;74:115-7.
10. Beier JC, Perkins PV, Onyango FK, et al. Characterization of malaria transmission by anopheles (diptera: culicidae) in Western Kenya in preparation for malaria vaccine trials. J Med Entomol 1990;27:570-7.
11. Linke A, Kuhn R, Muller W, Honarvar N, Li C, Langhorne J. Plasmodium chabaudi chabaudi: differential susceptibility of gene-targeted mice deficient in IL-10 to an erythrocytic-stage infection. Exp Parasitol 1996;84:253-63.
12. Kossodo S, Monso C, Juillard P, Velu T, Goldman M, Grau GE. Interleukin-10 modulates susceptibility in experimental cerebral malaria. Immunology 1997;91:536-40.
13. Clark IA, Chaudhri G. Tumour necrosis factor may contribute to the anaemia of malaria by causing dyserythropoiesis and erythrophagocytosis. Br J Heamatol 1998;70:99-103.
14. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnot PJ, Hutchinson IV. An investigation of polymorphism in the interleukin 10 gene promoter. Eur J Immunogenet 1997;24:1-8.
15. Grau GE, Heremans H, Piguet PF, et al. Monoclonal antibody against interferon-gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor-alpha. Proc Natl Acad Sci USA 1989;86:5572-4.